e-learning
resources
London 2016
Tuesday, 06.09.2016
Biomarkers and phenotypes of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Resting heart rate and exacerbations in COPD patients
Ahmad Izuanuddin Ismail (Selangor, Malaysia), Ahmad Izuanuddin Ismail, Aisya Natasya Musa, Mohd Arif Mohd Zim, Mohd Ariff Fadzil, Norhaya Mohd Razali, Razul Md Nazri Md Kassim, Tengku Saifudin Tengku Ismail
Source:
International Congress 2016 – Biomarkers and phenotypes of COPD
Session:
Biomarkers and phenotypes of COPD
Session type:
Thematic Poster
Number:
3666
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ahmad Izuanuddin Ismail (Selangor, Malaysia), Ahmad Izuanuddin Ismail, Aisya Natasya Musa, Mohd Arif Mohd Zim, Mohd Ariff Fadzil, Norhaya Mohd Razali, Razul Md Nazri Md Kassim, Tengku Saifudin Tengku Ismail. Resting heart rate and exacerbations in COPD patients. Eur Respir J 2016; 48: Suppl. 60, 3666
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
COPD: Influence of patients’ nutritive status on the exacerbations rate
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
One-year mortality in COPD patients after severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Mortality and readmissions in patients with severe COPD. Validation of the CODEX index
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Cardiovascular events (CVE) in COPD patients
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014
The frequency of COPD exacerbations is related to the comorbidity profile
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept